Fiber: 25-35g/day (psyllium husk if not getting enough)
Magnesium citrate 200-400mg/day at bedtime
Stool softener (docusate 100mg BID) if hard stool
Stimulant laxative (senna or bisacodyl) only short-term
When to hold or downtitrate
Hold escalation: if at any titration step, GI symptoms prevent normal eating/hydration for >5 days
Hold same dose: extend the step by 4 more weeks before next escalation
Downtitrate: back to previous step if symptoms persist on hold
Skip a week: if missed dose by >5 days, skip the dose entirely and resume next week
Red flags requiring clinician review
Severe persistent abdominal pain (especially radiating to back) — rule out pancreatitis (lipase, amylase)
Persistent vomiting >48h with inability to keep fluids down — dehydration risk
Right upper quadrant pain + nausea after fatty meals — gallstones
Mental status changes in T2D patients — hypoglycemia risk
Severe constipation with no bowel movement >5 days
Visual changes in retinopathy-prone patients (rare but reported)
Contraindications (do not use)
Personal or family history of medullary thyroid carcinoma (MTC)
Multiple endocrine neoplasia syndrome type 2 (MEN 2)
Hypersensitivity to semaglutide/tirzepatide
Pregnancy or breastfeeding (Category C)
Compare current GLP-1 telehealth pricing
Our 2026 Editor's Pick is NexLife for flat-rate compounded semaglutide and tirzepatide — $145/mo (sema) and $186/mo (tirz) on the 12-month plan. Six disclosed pharmacy partners, MD/DO oversight, Care360 coaching included.